News
PRPH
0.080
-13.03%
-0.012
Weekly Report: what happened at PRPH last week (0323-0327)?
Weekly Report · 5d ago
ProPhase Labs Delays Annual 10-K Yearly Filing
TipRanks · 03/27 23:04
Weekly Report: what happened at PRPH last week (0316-0320)?
Weekly Report · 03/23 09:26
ProPhase Labs says Crown Medical Collections effort ‘continues to advance’
TipRanks · 03/17 12:21
Weekly Report: what happened at PRPH last week (0309-0313)?
Weekly Report · 03/16 09:26
Weekly Report: what happened at PRPH last week (0302-0306)?
Weekly Report · 03/09 09:27
Weekly Report: what happened at PRPH last week (0223-0227)?
Weekly Report · 03/02 09:27
Weekly Report: what happened at PRPH last week (0216-0220)?
Weekly Report · 02/23 09:26
Weekly Report: what happened at PRPH last week (0209-0213)?
Weekly Report · 02/16 09:26
ProPhase Labs Explores Strategic Options for BE-Smart Test
TipRanks · 02/13 22:53
ProPhase Labs Hosts Investor Webinar on Growth Portfolio
TipRanks · 02/13 22:26
Weekly Report: what happened at PRPH last week (0202-0206)?
Weekly Report · 02/09 09:27
ProPhase Labs initiates potential sale, partnership for BE-Smart
TipRanks · 02/03 12:05
Weekly Report: what happened at PRPH last week (0126-0130)?
Weekly Report · 02/02 09:26
ProPhase Labs Issues Update on Crown Medical Collections
TipRanks · 01/27 16:27
ProPhase Labs provides Crown Medical Collections update
TipRanks · 01/26 12:10
Weekly Report: what happened at PRPH last week (0119-0123)?
Weekly Report · 01/26 09:26
ProPhase Labs Secures Flexible $10 Million Equity Facility
TipRanks · 01/23 22:55
ProPhase Labs Announces Uplisting to OTCID Market
TipRanks · 01/23 22:55
ProPhase Labs uplists from Pink Sheets to OTC Market
TipRanks · 01/22 12:05
More
Webull provides a variety of real-time PRPH stock news. You can receive the latest news about Prophase Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About PRPH
ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.